Pericardial Effusion - 21 Studies Found
Completed |
: Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC) : Lung Cancer : 2007-01-31 : Drug: IPI-504 IV Hsp90 inhibitor |
Completed |
: Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC) : Metastatic Non-squamous Non Small Cell Lung Cancer : 2009-07-17 :
|
Recruiting |
: The Effect of Chest Tubes Using Active Clearance Technology® on the Incidence of Postoperative Atrial Fibrillation :
|
Terminated |
: Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer :
: 2014-05-06 : |
Active, not recruiting |
: Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer :
|
Completed |
: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu :
|
Completed |
: QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer :
: |
Completed |
: Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer : Non Small Cell Lung Cancer : 2006-06-29 :
|
Completed |
: Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer : Lung Cancer : 2007-07-26 : Drug: Alimta 500 mg/m^2 by vein Once Over 10 Minutes Every 3 Weeks |
Completed |
: ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment :
: Drug: ILX-295501 |